MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Quantifiable changes in cortical visual processing in patients with Parkinson’s disease but no cognitive impairment

    R.S. Weil, B. Bahrami, D.S. Schwarzkopf, H. Burn, J.D. Warren, H.R. Morris (London, United Kingdom)

    Objective: To demonstrate quantifiable differences in cortical visual processing in patients with Parkinson's disease with no evidence of dementia, as compared to controls. Background: Visual…
  • 2016 International Congress

    Are limbic and cognitive effects on balance in Parkinson’s disease equal?

    K.A. Ehgoetz Martens, C.G. Ellard, Q.J. Almeida (Camperdown, Australia)

    Objective: The main objective of this study was to evaluate: (i)whether highly anxious PD (HA-PD) have a reduced capacity for information processing compared to PD…
  • 2016 International Congress

    Mild cognitive impairment in Parkinson’s disease: Impact on caregiver outcomes

    J.Y.Y. Szeto, M. Gilat, C.C. Walton, L. Mowszowski, S.L. Naismith, S.J.G. Lewis (Sydney, Australia)

    Objective: To utilise the newly established the International Parkinson and Movement Disorder Society (MDS) Task Force diagnostic criteria for Mild Cognitive Impairment (MCI) in Parkinson's…
  • 2016 International Congress

    Association between cognitive status and mobility performance in dual task condition in patients with Parkinson’s disease

    S.M.A.A. Pompeu, T.B. Freitas, K.G. Silva, C. Torriani-Pasin, F. Doná, J.E. Pompeu (São Paulo, Brazil)

    Objective: To analyzed the association of cognitive status (CS) and mobility performance in dual task conditions in Parkinson's disease patients (PDP) and to assess the…
  • 2016 International Congress

    Predictors of dementia in Parkinson’s disease: A population-based cohort study

    A. Keener, K. Paul, A. Folle, J. Bronstein, B. Ritz (Los Angeles, CA, USA)

    Objective: To evaluate and describe characteristics of Parkinson's disease (PD) patients who develop dementia during follow-up in a longitudinal study. Background: Important non-motor features of…
  • 2016 International Congress

    Response inhibition in Parkinson’s disease

    J. Kim, K. Zhang, M.A.I.U.A. Cruadhlaoich, S. YorkWilliams, V. Menon, K.L. Poston (Stanford, CA, USA)

    Objective: To study the brain networks underlying Response Inhibition in Parkinson's disease (PD). Background: While some PD patients can have significant executive dysfunction, others remain…
  • 2016 International Congress

    Transcranial sonography and cognitive dysfunction in Parkinson’s disease

    S. Behnke, A. Pilotto, I. Liepelt-Scarfone, R. Yilmaz, C. Pausch, S. Dieterich, I. Posner, J. Spiegel, U. Dillmann, M. Unger, B. Schmidl, J. Bürmann, K. Fassbender, D. Berg (Homburg Saar, Germany)

    Objective: To evaluate the role of transcranial sonography (TCS) in discriminating between Parkinson's disease (PD) patients with normal cognition (PDNC), mild cognitive impairment (PD-MCI) and…
  • 2016 International Congress

    Monoaminergic biomarkers of cognitive decline in Parkinson’s disease and Lewy body dementia

    S. van der Zee, Y. Vermeiren, T. Aerts, D. van Dam, M.J. Gerritsen, J.M. Spikman, T. van Laar, P.P. de Deyn (Groningen, Netherlands)

    Objective: The objective of this study was the identification of biochemical markers of cognitive impairment in Parkinson's disease (PD) and dementia with Lewy bodies (DLB)…
  • 2016 International Congress

    Unilateral subthalamotomy in Parkinson´s disease: Cognitive and neuropsychiatric effects and correlation with lesion size

    I. Obeso, E. Casabona, R. Rodríguez-Rojas, N. Pavón, R. Macías, M.L. Bringas, J.A. Obeso, M. Jahanshahi (Madrid, Spain)

    Objective: To assess cognitive and neuropsychiatric effects of unilateral subthalamotomy in Parkinson´s disease (PD) and their correlation with lesion size. Background: Surgery for treatment of…
  • 2016 International Congress

    Cognitive and psychiatric outcome 3 years after bilateral deep brain stimulation of the globus pallidus pars interna versus subthalamic nucleus for Parkinson’s disease

    J.A. Boel, V.J.J. Odekerken, G.J. Geurtsen, B.A. Schmand, M. Figee, R.J. de Haan, P. van den Munckhof, P.R. Schuurman, R.M.A. de Bie, The NSTAPS Study Group (Amsterdam, Netherlands)

    Objective: Comparing cognitive and psychiatric outcome 3 years after bilateral deep brain stimulation (DBS) of the globus pallidus pars interna (GPi) and subthalamic nucleus (STN)…
  • « Previous Page
  • 1
  • …
  • 1665
  • 1666
  • 1667
  • 1668
  • 1669
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley